Mary Zhang

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

The Air Traffic Control Association (ATCA) is an organization that aims to bring together all stakeholders who manage airspace integration throughout the globe. The private company is based in Alexandria, VA. The company's theme is "Connecting People to Shape Tomorrow's Airspace." The association elects its leadership from its members. ATCA hosts a premier technical event called the Symposium, which focuses on the latest ideas, research, products, and services in the air traffic management arena. After a long suspension due to the pandemic, ATCA, along with its Tech Symposium co-chairs FAA and NASA, is excited to announce the return of the in-person Tech Symposium in April 2023. The CEO of the company is Peter F. Dumont.

Veracity Engineering LLC provides engineering and program management services to aviation and transportation sectors. It specializes in communications support, navigation, surveillance, security, and safety programs. Its services include program management, technology development, systems engineering and integration, network design and management, software design and development and asset management. The company was founded by Hai N. Tran in 2001 and is headquartered in Washington, DC.

Material Impact Management LLC (Material Impact Management) is a venture capital firm founded in 2015 by Carmichael Roberts and Adam Sharkawy. The firm is headquartered in Boston, Massachusetts.

Maxfield Enterprises, Inc. is a private company that retails men and boy's clothing stores. The company is based in Los Angeles, CA.

Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA.

Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation.